Bioceres Crop Solutions Corp. BIOX
0.37
0.00
0.00%
as of 25 Sep
- Market cap
- $23.5M
- P/E
- 0.0×
Follow BIOX
Growth Flags
show if company had growth for consecutive years
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.11 | 0.28 | 0.28 | 0.85 | |
P/FCF ratio |
0.36 | 1.06 | 1.66 | 6.38 | |
P/Operating CF |
1.65 | 4.78 | 6.22 | 10.56 | |
P/B ratio |
0.27 | 0.78 | 0.31 | 0.96 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 150.17 | |
EV/Sales |
0.50 | 0.67 | 0.67 | 1.22 | |
EV/EBITDA |
7.28 | 10.57 | 8.37 | 20.35 | |
EV/Operating CF |
1.64 | 2.38 | 3.58 | 8.13 | |
EV/FCF |
1.71 | 2.48 | 3.92 | 9.16 | |
Quick Ratio |
0.56 | 0.56 | 0.65 | 0.65 | |
Current Ratio |
0.88 | 0.90 | 0.94 | 0.91 | |
Net Debt/EBITDA |
0.00 | 12.82 | 9.38 | (8.22) | |
Debt/Assets |
22.75% | 22.17% | 18.91% | 20.68% | |
Debt/Equity |
1.26 | 1.17 | 0.48 | 0.53 | |
Asset Turnover |
0.41 | 0.42 | 0.41 | 0.41 | |
Operating CF/Net income |
0.00 | (0.09) | (1.96) | (0.56) | |
Capex/Depreciation |
— | 0.03 | (0.12) | (0.05) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 3.18% | 7.40% | 6.05% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 23.23% | 29.95% | 51.45% | |
Intangible Assets out of Total Assets |
0.23 | 0.22 | 0.40 | 0.38 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 1.28% | |
Graham Net Nets |
(6.05) | (1.92) | (1.83) | (0.57) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(857.78%) | (283.97%) | (59.57%) | (18.12%) | |
Free Cash Flow Yield |
274.38% | 94.44% | 60.35% | 15.68% | |
Revenue per Share |
0.62 | 1.16 | 1.22 | 1.27 | |
Operating CF per Share |
0.00 | 0.27 | 0.23 | 0.42 | |
Capex per Share |
0.00 | 0.00 | (0.01) | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.27 | 0.22 | 0.42 | |
Cash per Share |
0.23 | 0.20 | 0.26 | 0.55 | |
Shareholders Equity per Share |
1.50 | 1.68 | 4.55 | 4.67 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.50 | 1.68 | 4.55 | 4.67 | |
Free Cash Flow |
— | 17.43 | 13.67 | 26.52 | |
Working Capital |
(36.80) | (34.36) | (16.56) | (29.67) | |
Capital Expenditures |
— | 0.04 | (0.70) | (0.25) | |
Net Current Asset Value |
(173.20) | (159.47) | (163.40) | (160.11) | |
EV/EBIT |
0.00 | 0.00 | 81.35 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.01 | 0.00 | |
Net Profit Margin |
(22.84%) | (248.00%) | (9.49%) | (59.45%) | |
Price to Operating Income |
0.00 | 0.00 | 34.36 | 0.00 | |
| Other line items | |||||
Average Receivables |
178.07 | 208.67 | 198.21 | 204.93 | |
Average Payables |
104.10 | 116.72 | 123.03 | 132.58 | |
Average Inventory |
73.11 | 86.68 | 105.12 | 108.11 | |
Average Assets |
663.91 | 697.78 | 781.07 | 808.10 | |
Average Common Equity |
— | 226.47 | 317.18 | 323.30 |
Columns are period end dates